Skip to Content

Pfizer PBC 75 (Ibrance 75 mg)

Generic Name: palbociclib

Pill with imprint Pfizer PBC 75 is Orange, Capsule-shape and has been identified as Ibrance 75 mg. It is supplied by Pfizer Inc..

Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Pfizer PBC 75

Ibrance

Generic Name:
palbociclib
Imprint:
Pfizer PBC 75
Strength:
75 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-0187

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide